Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation

INTRODUCTION: Long wait times for kidney transplants have prompted investigation into strategies to decrease the discarding of potentially viable organs. Recent reports suggest that kidneys from hepatitis C virus (HCV)−infected donors may be transplanted into HCV-naive donors followed by direct-acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sise, Meghan E., Strohbehn, Ian A., Chute, Donald F., Gustafson, Jenna, Van Deerlin, Vivianna M., Smith, Jennifer R., Gentile, Caren, Wojciechowski, David, Williams, Winfred W., Elias, Nahel, Chung, Raymond T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136432/
https://www.ncbi.nlm.nih.gov/pubmed/32280841
http://dx.doi.org/10.1016/j.ekir.2020.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136432/
https://www.ncbi.nlm.nih.gov/pubmed/32280841
http://dx.doi.org/10.1016/j.ekir.2020.01.001

Ejemplares similares